Psychiatric diagnoses have been controversial for decades as there have never been any physical or medical tests to confirm any of the disorders listed in their several versions of the American Psychiatric Association’s “Diagnostic and Statistical Manual of Mental Disorders.” With the expansion of telepsychiatry following the lessening of restrictions in the March 2020’s COVID-19 stimulus package, the reason for this controversy is further confirmed. Psychiatry is now regularly diagnosing, labeling and drugging people through the internet that they have never met. You cannot possibly do a physical work-up on a person without seeing them.

In March, $1.7 billion was allocated to mental health programs in response to COVID-19 fears and concerns, The federal stimulus package that should have been geared to supporting out-of-work citizens included $425 million for mental health services and an additional $1.32 billion for community mental health centers. This funding created a large expansion of psychiatry that already has a psychiatric drug market worth over $35 billion a year in the U.S. alone—and potentially sentencing consumers to a lifetime of side effects and harm while they are already drugging 1/6th the US population. As you can see, the pandemic of psychiatric drugging likely dwarfs that of the coronavirus.

One of the many mental health organizations taking advantage of this new money is the Connecticut-based telepsychiatry company , Cerebral. They lure people in with advertisements of cheap first month mental health deals without openly showing the dangers of the psychiatric drugs they intend to prescribe people without ever seeing them in person. You can see many of the studies proving the extreme frequency and harm from psychotropic drugs by clicking here:

Another waiver allows them to prescribe controlled substances (highly addictive psychotropic drugs) via the Internet. The drugs, as previously mentioned, come with serious risks and side effects

Around the beginning of the pandemic, an American Psychiatric Association survey of 1,004 Americans deduced that over 40% of the nation was anxious about dying or becoming seriously ill from COVID-19. It didn’t take long for their lobbying efforts to take advantage of this predictable reaction of fear and anxiety to turn more people into labeled and drugged mental patients for their profit. Obviously, our government should take action to reverse the harmful telepsychiatry funding and regulations they created.